Parand Darou Named National Exemplary Exporter of 2024: A Milestone in Pharmaceutical Innovation
On Sunday, October 20, 2024, coinciding with National Export Day, Parand Darou Pharmaceutical Company was honored at the Summit Hall in Tehran. In a ceremony attended by the President of the Islamic Republic of Iran and the Minister of Industry, Mine and Trade, Parand Darou was awarded the Certificate of Merit and the Golden Statue as the National Exemplary Exporter of the year 2024 in the “High-Complexity and Knowledge-Based Goods” category.
This prestigious recognition honors Parand Darou’s outstanding contributions to the production and export of narcotic and non-narcotic Active Pharmaceutical Ingredients (APIs), as well as its pivotal role in advancing Iran’s pharmaceutical industry, particularly regarding foreign exchange revenue and a positive trade balance.
Operating since 2006 under the slogan “Flying to the Skies of Health,” Parand Darou has established itself as a pioneer in the knowledge-based sector. As the second private company in Iran to receive the license for producing narcotic APIs, the firm continues to set industry benchmarks. By employing strategies focused on quality-driven product development, export-oriented market expansion, and profit-driven optimized production, the company now serves 8 global markets with 6 key pharmaceutical products.
Criteria for National Exemplary Exporter Selection
- Market penetration depth and stability
- Number of new export markets entered
- Product complexity and knowledge-based coefficient
- Technology transfer and local localization efforts
- Future strategic and development planning
- Currency repatriation coefficient
- Export value over the past three years
- Active membership in Joint Chambers of Commerce
- Management and board specialized certifications
- Patent registrations in destination countries
- Adherence to international standard certifications
- Active presence in international exhibitions
- Multilingual digital presence and targeted advertising
- Strict compliance with currency repatriation regulations
A Strategic Achievement: While Iran’s non-oil trade balance for 2023 faced a deficit of approximately $17 billion, Parand Darou achieved a positive trade balance, with exports nearly 4 times its imports. This outstanding performance ranks Parand Darou as the #1 company among all API manufacturers and the #2 company in the entire Iranian pharmaceutical industry in terms of positive trade balance generation.
